• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

外科医生及经尿道切除术在浅表性膀胱癌治疗中的作用。

The role of the surgeon and transurethral resection in the treatment of superficial bladder cancer.

作者信息

Nieder Alan M, Manoharan Murugesan

机构信息

Department of Urology, University of Miami Miller School of Medicine, Miami, FL, USA.

出版信息

ScientificWorldJournal. 2006 Jun 7;6:2626-31. doi: 10.1100/tsw.2006.405.

DOI:10.1100/tsw.2006.405
PMID:17619740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5917271/
Abstract

Non-muscle invasive bladder cancers are a heterogeneous group of cancers whose spectrum includes low grade Ta lesions and high-grade T1 lesions. Accurate staging and grading during initial evaluation and TUR ensures appropriate treatment and prevents the risk of understaging. TUR should be ideally performed under spinal anesthesia, with a continuous flow video resectoscope to maintain a stable bladder capacity, and a video monitor. The entire bladder must be visualized, with both 30- and 70-degree lenses, and all abnormal areas must be resected, with separate biopsies from each tumor's base. Repeat TUR is recommended for all high grade tumors and T1 tumors, especially if muscle was not present in the initial specimen. Immediate instillation of single dose chemotherapy agents following TUR is highly recommended to reduce the risk of tumor recurrences.

摘要

非肌肉浸润性膀胱癌是一组异质性癌症,其范围包括低级别Ta病变和高级别T1病变。在初始评估和经尿道膀胱肿瘤切除术(TUR)期间进行准确的分期和分级可确保适当的治疗并防止分期不足的风险。理想情况下,TUR应在脊髓麻醉下进行,使用连续冲洗式视频电切镜以维持稳定的膀胱容量,并配备视频监视器。必须使用30度和70度镜头观察整个膀胱,所有异常区域都必须切除,并从每个肿瘤的基底单独取材活检。对于所有高级别肿瘤和T1肿瘤,尤其是初始标本中未发现肌肉组织的情况,建议重复进行TUR。强烈建议在TUR后立即灌注单剂量化疗药物以降低肿瘤复发风险。

相似文献

1
The role of the surgeon and transurethral resection in the treatment of superficial bladder cancer.外科医生及经尿道切除术在浅表性膀胱癌治疗中的作用。
ScientificWorldJournal. 2006 Jun 7;6:2626-31. doi: 10.1100/tsw.2006.405.
2
Oncological outcomes of a single but extensive transurethral resection followed by appropriate intra-vesical instillation therapy for newly diagnosed non-muscle-invasive bladder cancer.对于新诊断的非肌层浸润性膀胱癌,单次广泛经尿道切除术后联合适当的膀胱内灌注治疗的肿瘤学结局。
Int Urol Nephrol. 2015 Sep;47(9):1509-14. doi: 10.1007/s11255-015-1048-3. Epub 2015 Jul 7.
3
Management of high-risk non-muscle invasive bladder cancer.高危非肌层浸润性膀胱癌的管理
Minerva Urol Nefrol. 2012 Dec;64(4):255-60.
4
Retrospective analysis of transurethral resection, second-look resection, and long-term chemo-metaphylaxis for superficial bladder cancer: indications and efficacy of a differentiated approach.浅表性膀胱癌经尿道切除术、二次探查切除术及长期化疗预防的回顾性分析:差异化治疗方法的适应证及疗效
J Endourol. 2007 Dec;21(12):1533-41. doi: 10.1089/end.2007.9866.
5
Repeat transurethral resection for non-muscle-invasive bladder cancer: a contemporary series.非肌层浸润性膀胱癌的重复经尿道切除术:当代系列研究
BJU Int. 2016 Apr;117 Suppl 4:54-9. doi: 10.1111/bju.13265. Epub 2015 Oct 21.
6
Randomized trial of narrow-band versus white-light cystoscopy for restaging (second-look) transurethral resection of bladder tumors.随机试验:窄带光与白光膀胱镜用于经尿道膀胱肿瘤切除术后的复查(二次探查)。
Eur Urol. 2015 Apr;67(4):605-8. doi: 10.1016/j.eururo.2014.06.049. Epub 2014 Jul 17.
7
Diffusion-weighted magnetic resonance imaging in follow-up of superficial urinary bladder carcinoma after transurethral resection: initial experience.经尿道切除术后浅表性膀胱癌随访中扩散加权磁共振成像:初步经验。
BJU Int. 2012 Dec;110(11 Pt B):E622-7. doi: 10.1111/j.1464-410X.2012.11345.x. Epub 2012 Jul 3.
8
Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?泌尿外科医生能否通过评估内镜照片准确分期和分级尿路上皮膀胱癌?
J Telemed Telecare. 2018 Oct;24(9):603-607. doi: 10.1177/1357633X17727773. Epub 2017 Sep 18.
9
The use of local anesthesia with N-DO injector (Physion) for transurethral resection (TUR) of bladder tumors and bladder mapping: preliminary results and cost-effectiveness analysis.
Eur Urol. 2007 Nov;52(5):1407-11. doi: 10.1016/j.eururo.2007.04.086. Epub 2007 May 11.
10
[Second resection in patients with Ta-T1 bladder tumors].
Actas Urol Esp. 2001 Sep;25(8):553-8. doi: 10.1016/s0210-4806(01)72671-x.

引用本文的文献

1
Is Obturator Nerve Block Effective as Spinal Anesthesia in Preventing Adductor Spasms in General Anesthesia Without Muscle Relaxants?闭孔神经阻滞在无肌肉松弛剂的全身麻醉中预防内收肌痉挛方面与脊髓麻醉效果相同吗?
Cureus. 2022 Feb 18;14(2):e22365. doi: 10.7759/cureus.22365. eCollection 2022 Feb.
2
Classic versus Inguinal Approach for Obturator Nerve Block in Transurethral Resection of Bladder Cancer under Spinal Anesthesia: A Randomized Controlled Trial.脊髓麻醉下经尿道膀胱癌切除术闭孔神经阻滞的经典与腹股沟入路:一项随机对照试验
Iran J Med Sci. 2018 Jan;43(1):75-80.
3
The Role of Transurethral Resection in Trimodal Therapy for Muscle-Invasive Bladder Cancer.经尿道切除术在肌层浸润性膀胱癌三联疗法中的作用。
Bladder Cancer. 2016 Oct 27;2(4):381-394. doi: 10.3233/BLC-160076.
4
Emerging endoscopic and photodynamic techniques for bladder cancer detection and surveillance.用于膀胱癌检测和监测的新兴内镜及光动力技术。
ScientificWorldJournal. 2011;11:2550-8. doi: 10.1100/2011/412739. Epub 2011 Dec 29.